Advertisement
Mayo Clinic Proceedings Home

Oral Cancer

  • Deepak Kademani
    Correspondence
    Address correspondence to Deepak Kademani, DMD, MD, Division of Oral Diagnosis and Oral and Maxillofacial Surgery, Mayo Clinic, 200 First St SW, Rochester, Minn 55905
    Affiliations
    Division of Oral Diagnosis and Oral and Maxillofacial Surgery, Mayo Clinic, Rochester, Minn
    Search for articles by this author
      Five percent of all tumors occur in the head and neck, and approximately half of those occur specifically in the oral cavity. Of the 615,000 new cases of oral cavity tumors reported worldwide in 2000, 300,000 were primary oral cavity squamous cell carcinomas. Recent data from the Surveillance, Epidemiology, and End Results Program suggest that 28,900 new cases of oral cancer will be identified and 7400 deaths attributed to oral cancer each year in the United States. The sixth leading cause of cancer-related mortality, oral cancer accounts for 1 death every hour in the United States. However, despite advances in screening tools, imaging technology, and access to primary care physicians, a considerable percentage of patients present with advanced-stage disease. Clinical signs and symptoms of head and neck tumors are often nonspecific and may be mistaken for other common ailments. Primary care physicians must be aware of the possibility of oral cancer, particularly the increasing incidence in young patients without traditional risk factors of alcohol and tobacco abuse. To improve survival, all patients should be routinely and vigilantly screened for oral mucosal lesions.
      ECS (extracapsular spread), HPV (human papilloma virus), OCSCC (oral cavity squamous cell carcinoma)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Silverman Jr, S
        Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge.
        J Am Dent Assoc. 2001; 132: 7S-11S
        • Swango PA
        Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview.
        J Public Health Dent. 1996; 56: 309-318
        • Chen JK
        • Katz RV
        • Krutchkoff DJ
        Intraoral squamous cell carcinoma: epidemiologic patterns in Connecticut from 1935 to 1985.
        Cancer. 1990; 66: 1288-1296
        • Silverman Jr, S
        • Gorsky M
        Epidemiologic and demographic update in oral cancer: California and national data: 1973 to 1985.
        J Am Dent Assoc. 1990; 120: 495-499
        • Llewellyn CD
        • Johnson NW
        • Warnakulasuriya KA
        Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review.
        Oral Oncol. 2001; 37: 401-418
        • Silverman Jr, S
        • Gorsky M
        • Lozada F
        Oral leukoplakia and malignant transformation: a follow-up study of 257 patients.
        Cancer. 1984; 53: 563-568
        • Silverman Jr, S
        Observations on the clinical characteristics and natural history of oral leukoplakia.
        J Am Dent Assoc. 1968; 76: 772-777
        • Jemal A
        • Tiwari RC
        • Murray T
        • American Cancer Society
        • et al.
        Cancer statistics, 2004.
        CA Cancer J Clin. 2004; 54: 8-29
        • Smith RA
        • Cokkinides V
        • von Eschenbach AC
        • American Cancer Society
        • et al.
        American Cancer Society guidelines for the early detection of cancer.
        CA Cancer J Clin. 2002; 52: 8-22
        • Smart CR
        Screening for cancer of the aerodigestive tract.
        Cancer. 1993; 72: 1061-1065
        • Holmes JD
        • Dierks EJ
        • Homer LD
        • Potter BE
        Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis?.
        J Oral Maxillofac Surg. 2003; 61: 285-291
        • Rindum J
        • Pindborg JJ
        Intraoral cancer: 100 consecutive cases [in Danish].
        Tandlaegebladet. 1989; 93: 504-505
        • Schnetler JF
        Oral cancer diagnosis and delays in referral.
        Br J Oral Maxillofac Surg. 1992; 30: 210-213
        • Hollows P
        • McAndrew PG
        • Perini MG
        Delays in the referral and treatment of oral squamous cell carcinoma [published correction appears in Br Dent J. 2000;188:380].
        Br Dent J. 2000; 188: 262-265
        • Sankaranarayanan R
        • Ramadas K
        • Thomas G
        • Trivandrum Oral Cancer Screening Study Group
        • et al.
        Effect of screening oral cancer mortality in Kerala, India: a cluster-randomised controlled trial.
        Lancet. 2005; 365: 1927-1933
        • Bouquot JE
        Common oral lesions found during a mass screening examination.
        J Am Dent Assoc. 1986; 112: 50-57
        • Johnson N
        Tobacco use and oral cancer: a global perspective.
        J Dent Educ. 2001; 65: 328-339
        • Horowitz AM
        • Goodman HS
        • Yellowitz JA
        • Nourjah PA
        The need for health promotion in oral cancer prevention and early detection.
        J Public Health Dent. 1996; 56: 319-330
      1. Ries LAG, Harkins D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2003, Bethesda, Md: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER Web site, 2006.

        • Mao L
        • Hong WK
        • Papadimitrakopoulou VA
        Focus on head and neck cancer.
        Cancer Cell. 2004; 5: 311-316
        • Lewin F
        • Norell SE
        • Johansson H
        • et al.
        Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden.
        Cancer. 1998; 82: 1367-1375
        • Jovanovic A
        • Schulten EA
        • Kostense PJ
        • Snow GB
        • van der Waal I
        Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma.
        J Oral Pathol Med. 1993; 22: 459-462
        • Mashberg A
        • Boffetta P
        • Winkelman R
        • Garfinkel L
        Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans.
        Cancer. 1993; 72: 1369-1375
        • Blot WJ
        • McLaughlin JK
        • Winn DM
        • et al.
        Smoking and drinking in relation to oral and pharyngeal cancer.
        Cancer Res. 1988; 48: 3282-3287
        • Decker J
        • Goldstein JC
        Risk factors in head and neck cancer.
        N Engl J Med. 1982; 306: 1151-1155
        • Silverman Jr, S
        • Griffith M
        Smoking characteristics of patients with oral carcinoma and the risk for second oral primary carcinoma.
        J Am Dent Assoc. 1972; 85: 637-640
        • Reibel J
        Tobacco and oral diseases: update on the evidence, with recommendations.
        Med Princ Pract. 2003; 12: 22-32
        • Singh B
        • Bhaya M
        • Zimbler M
        • et al.
        Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
        Head Neck. 1998; 20: 1-7
        • Schantz SP
        • Yu GP
        Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer.
        Arch Otolaryngol Head Neck Surg. 2002; 128: 268-274
        • Mork J
        • Lie AK
        • Glattre E
        • et al.
        Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
        N Engl J Med. 2001; 344: 1125-1131
        • Gillison ML
        • Shah KV
        Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers.
        Curr Opin Oncol. 2001; 13: 183-188
        • Lindel K
        • Beer KT
        • Laissue J
        • Greiner RH
        • Aebersold DM
        Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma.
        Cancer. 2001; 92: 805-813
        • Sugerman PB
        • Shillitoe EJ
        The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship.
        Oral Dis. 1997; 3: 130-147
        • Miller CS
        • White DK
        Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82: 57-68
        • Smith EM
        • Ritchie JM
        • Summersgill KF
        • et al.
        Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
        Int J Cancer. 2004; 108: 766-772
        • Klussmann JP
        • Weissenborn SJ
        • Wieland U
        • et al.
        Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.
        Cancer. 2001; 92: 2875-2884
        • Mellin H
        • Friesland S
        • Lewensohn R
        • Dalianis T
        • Munck-Wikland E
        Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival.
        Int J Cancer. 2000; 89: 300-304
        • Ritchie JM
        • Smith EM
        • Summersgill KF
        • et al.
        Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
        Int J Cancer. 2003; 104: 336-344
        • Day GL
        • Blot WJ
        Second primary tumors in patients with oral cancer.
        Cancer. 1992; 70: 14-19
        • Johnson NW
        • Warnakulasuriya KA
        Oral cancer: is it more common than cervical?.
        Br Dent J. 1991; 170: 170-171
        • Johnson NW
        • Warnakulasuriya KA
        Epidemiology and aetiology of oral cancer in the United Kingdom.
        Community Dent Health. 1993; 10: 13-29
        • Moore SR
        • Johnson NW
        • Pierce AM
        • Wilson DF
        The epidemiology of mouth cancer: a review of global incidence.
        Oral Dis. 2000; 6: 65-74
        • Shah JP
        Cervical lymph node metastases: diagnostic, therapeutic, and prognostic implications.
        Oncology (Williston Park). 1990; 4: 61-69
        • Woolgar JA
        • Scott J
        Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth.
        Head Neck. 1995; 17: 463-472
        • Slaughter DP
        • Southwick HW
        • Smejkal W
        Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin.
        Cancer. 1953; 6: 963-968
        • Brennan JA
        • Boyle JO
        • Koch WM
        • et al.
        Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
        N Engl J Med. 1995; 332: 712-717
        • Andre K
        • Schraub S
        • Mercier M
        • Bontemps P
        Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France.
        Eur J Cancer B Oral Oncol. 1995; 31B: 301-309
        • Kaugars GE
        • Riley WT
        • Brandt RB
        • Burns JC
        • Svirsky JA
        The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors.
        Cancer. 1992; 70: 2579-2585
        • Winn DM
        • Blot WJ
        • Shy CM
        • Pickle LW
        • Toledo A
        • Fraumeni Jr, JF
        Snuff dipping and oral cancer among women in the southern United States.
        N Engl J Med. 1981; 304: 745-749
        • Grady D
        • Greene J
        • Daniels TE
        • et al.
        Oral mucosal lesions found in smokeless tobacco users.
        J Am Dent Assoc. 1990; 121: 117-123
        • Bouquot JE
        • Meckstroth RL
        Oral cancer in a tobacco-chewing US population: no apparent increased incidence or mortality.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 697-706
        • Elwood JM
        • Pearson JC
        • Skippen DH
        • Jackson SM
        Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx.
        Int J Cancer. 1984; 34: 603-612
        • Miller PM
        • Day TA
        • Ravenel MC
        Clinical implications of continued alcohol consumption after diagnosis of upper aerodigestive tract cancer.
        Alcohol Alcohol. 2006 Mar-Apr; 41 (Epub 2005 Nov 24.): 140-142
        • Day GL
        • Blot WJ
        • Shore RE
        • et al.
        Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol.
        J Natl Cancer Inst. 1994; 86: 131-137
        • Parkin DM
        • Laara E
        • Muir CS
        Estimates of the worldwide frequency of sixteen major cancers in 1980.
        Int J Cancer. 1988; 41: 184-197
        • Pindborg JJ
        • Mehta FS
        • Gupta PC
        • Daftary DK
        • Smith CJ
        Reverse smoking in Andhra Pradesh, India: a study of palatal lesions among 10,169 villagers.
        Br J Cancer. 1971; 25: 10-20
        • Johnson NW
        Orofacial neoplasms: global epidemiology, risk factors and recommendations for research.
        Int Dent J. 1991; 41: 365-375
        • Pindborg JJ
        • Murti PR
        • Bhonsle RB
        • Gupta PC
        • Daftary DK
        • Mehta FS
        Oral submucous fibrosis as a precancerous condition.
        Scand J Dent Res. 1984; 92: 224-229
        • Murti PR
        • Bhonsle RB
        • Pindborg JJ
        • Daftary DK
        • Gupta PC
        • Mehta FS
        Malignant transformation rate in oral submucous fibrosis over a 17-year period.
        Community Dent Oral Epidemiol. 1985; 13: 340-341
        • Murti PR
        • Bhonsle RB
        • Gupta PC
        • Daftary DK
        • Pindborg JJ
        • Mehta FS
        Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing.
        J Oral Pathol Med. 1995; 24: 145-152
        • Brennan JA
        • Mao L
        • Hruban RH
        • et al.
        Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
        N Engl J Med. 1995; 332: 429-435
        • Brachman DG
        • Graves D
        • Vokes E
        • et al.
        Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
        Cancer Res. 1992; 52: 4832-4836
        • Brachman DG
        Molecular biology of head and neck cancer.
        Semin Oncol. 1994; 21: 320-329
        • Shin DM
        • Charuruks N
        • Lippman SM
        • et al.
        p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
        Cancer Epidemiol Biomarkers Prev. 2001; 10: 603-609
        • Nawroz H
        • van der Riet P
        • Hruban RH
        • Koch W
        • Ruppert JM
        • Sidransky D
        Allelotype of head and neck squamous cell carcinoma.
        Cancer Res. 1994; 54: 1152-1155
        • van der Riet P
        • Nawroz H
        • Hruban RH
        • et al.
        Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
        Cancer Res. 1994; 54: 1156-1158
        • Jones KR
        • Lodge-Rigal RD
        • Reddick RL
        • Tudor GE
        • Shockley WW
        Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity.
        Arch Otolaryngol Head Neck Surg. 1992; 118: 483-485
        • WHO Collaborating Centre for Oral Precancerous Lesions
        Definition of leukoplakia and related lesions: an aid to studies on oral precancer.
        Oral Surg Oral Med Oral Pathol. 1978; 46: 518-539
        • Axell T
        • Holmstrup P
        • Kramer IRH
        • Pindborg JJ
        • Shear M
        International seminar on oral leukoplakia and associated lesions related to tobacco habits.
        Community Dent Oral Epidemiol. 1984; 12: 145-154
        • Axell T
        • Pindborg JJ
        • Smith CJ
        • van der Waal I
        • International Collaborative Group on Oral White Lesions
        Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994.
        J Oral Pathol Med. 1996; 25: 49-54
        • Bouquot JE
        Reviewing oral leukoplakia: clinical concepts for the 1990s.
        J Am Dent Assoc. 1991; 122: 80-82
        • Bouquot J
        • Weiland L
        • Ballard D
        • Kurland L
        Leukoplakia of the mouth and pharynx in Rochester, MN, 1935-1984: incidence, clinical features and follow-up of 463 patients from a relatively unbiased patient pool [abstract].
        J Oral Pathol. 1988; 17: 436
        • Waldron CA
        • Shafer WG
        Leukoplakia revisited: a clinicopathologic study 3256 oral leukoplakias.
        Cancer. 1975; 36: 1386-1392
        • Lee JJ
        • Hong WK
        • Hittelman WN
        • et al.
        Predicting cancer development in oral leukoplakia: ten years of translational research.
        Clin Cancer Res. 2000; 6: 1702-1710
        • Bouquot JE
        • Gorlin RJ
        Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years.
        Oral Surg Oral Med Oral Pathol. 1986; 61: 373-381
        • Banoczy J
        • Csiba A
        Occurrence of epithelial dysplasia in oral leukoplakia: analysis and follow-up study of 12 cases.
        Oral Surg Oral Med Oral Pathol. 1976; 42: 766-774
        • Schepman KP
        • van der Meij EH
        • Smeele LE
        • van der Waal I
        Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
        Oral Oncol. 1998; 34: 270-275
        • Kademani D
        • Dierks E
        Surgical management of oral and mucosal dysplasias: the case for surgical excision.
        J Oral Maxillofac Surg. 2007; 65: 287-292
        • Lumerman H
        • Freedman P
        • Kerpel S
        Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79: 321-329
        • Mashberg A
        • Samit A
        Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers.
        CA Cancer J Clin. 1995; 45: 328-351
        • Shafer WG
        • Waldron CA
        Erythroplakia of the oral cavity.
        Cancer. 1975; 36: 1021-1028
        • Saito T
        • Sugiura C
        • Hirai A
        • et al.
        Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.
        Int J Oral Maxillofac Surg. 2001; 30: 49-53
        • Vigliante CE
        • Quinn PD
        • Alawi F
        Proliferative verrucous leukoplakia: report of a case with characteristic long-term progression.
        J Oral Maxillofac Surg. 2003; 61: 626-631
        • Bagan JV
        • Jimenez Y
        • Sanchis JM
        • et al.
        Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
        J Oral Pathol Med. 2003; 32: 379-382
        • Silverman Jr, S
        • Gorsky M
        Proliferative verrucous leukoplakia: a follow-up study of 54 cases.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84: 154-157
        • Barnard NA
        • Scully C
        • Eveson JW
        • Cunningham S
        • Porter SR
        Oral cancer development in patients with oral lichen planus.
        J Oral Pathol Med. 1993; 22: 421-424
        • Kademani D
        • Bell RB
        • Bagheri S
        • et al.
        Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
        J Oral Maxillofac Surg. 2005; 63: 1599-1605
      2. Head and neck sites.
        in: Greene FL Page DL Fleming ID AJCC Cancer Staging Manual. 6th ed. Springer-Verlag, New York, NY2002: 17-87
        • Woolley E
        • Magennis P
        • Shokar P
        • Lowe D
        • Edwards D
        • Rogers SN
        The correlation between indices of deprivation and health-related quality of life in patients with oral and oropharyngeal squamous cell carcinoma.
        Br J Oral Maxillofac Surg. 2006 Jun; 44 (Epub 2005 Aug 18.): 177-186
        • Chandu A
        • Smith AC
        • Rogers SN
        Health-related quality of life in oral cancer: a review.
        J Oral Maxillofac Surg. 2006; 64: 495-502
        • Woolgar JA
        • Rogers S
        • West CR
        • Errington RD
        • Brown JS
        • Vaughan ED
        Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.
        Oral Oncol. 1999; 35: 257-265
        • Shah JP
        Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract.
        Am J Surg. 1990; 160: 405-409
        • Spiro RH
        • Huvos AG
        • Wong GY
        • Spiro JD
        • Gnecco CA
        • Strong EW
        Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth.
        Am J Surg. 1986; 152: 345-350
        • Johnson JT
        • Barnes EL
        • Myers EN
        • Schramm Jr, VL
        • Borochovitz D
        • Sigler BA
        The extracapsular spread of tumors in cervical node metastasis.
        Arch Otolaryngol. 1981; 107: 725-729
        • de Bree R
        • Deurloo EE
        • Snow GB
        • Leemans CR
        Screening for distant metastases in patients with head and neck cancer.
        Laryngoscope. 2000; 110: 397-401
        • Matsuo JM
        • Patel SG
        • Singh B
        • et al.
        Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx.
        Ann Surg. 2003; 238: 412-421
        • Al-Othman MO
        • Morris CG
        • Hinerman RW
        • Amdur RJ
        • Mendenhall WM
        Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck.
        Head Neck. 2003; 25: 629-633
        • Kowalski LP
        • Carvalho AL
        • Martins Priante AV
        • Magrin J
        Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma.
        Oral Oncol. 2005 May; 41 (Epub 2005 Apr 9.): 534-541
        • Younes RN
        • Gross JL
        • Silva JF
        • Fernandez JA
        • Kowalski LP
        Surgical treatment of lung metastases of head and neck tumors.
        Am J Surg. 1997; 174: 499-502
        • Pearlman NW
        Treatment outcome in recurrent head and neck cancer.
        Arch Surg. 1979; 114: 39-42
        • Nathanson A
        • Agren K
        • Biorklund A
        • et al.
        Evaluation of some prognostic factors in small squamous cell carcinoma of the mobile tongue: a multicenter study in Sweden.
        Head Neck. 1989; 11: 387-392
        • van Es RJ
        • van Nieuw Amerongen N
        • Slootweg PJ
        • Egyedi P
        Resection margin as a predictor of recurrence at the primary site for T1 and T2 oral cancers: evaluation of histopathologic variables.
        Arch Otolaryngol Head Neck Surg. 1996; 122: 521-525
        • Slootweg PJ
        • Hordijk GJ
        • Schade Y
        • van Es RJ
        • Koole R
        Treatment failure and margin status in head and neck cancer: a critical view on the potential value of molecular pathology.
        Oral Oncol. 2002; 38: 500-503
        • McGuirt Jr, WF
        • Johnson JT
        • Myers EN
        • Rothfield R
        • Wagner R
        Floor of mouth carcinoma: the management of the clinically negative neck.
        Arch Otolaryngol Head Neck Surg. 1995; 121: 278-282
        • Peters LJ
        • Goepfert H
        • Ang KK
        • et al.
        Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
        Int J Radiat Oncol Biol Phys. 1993; 26: 3-11
        • Cooper JS
        • Pajak TF
        • Forastiere AA
        • Radiation Therapy Oncology Group 9501/Intergroup
        • et al.
        Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
        N Engl J Med. 2004; 350: 1937-1944
        • Bernier J
        • Domenge C
        • Ozsahin M
        • European Organization for Research and Treatment of Cancer Trial 22931
        • et al.
        Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
        N Engl J Med. 2004; 350: 1945-1952
        • Salama JK
        • Vokes EE
        • Chmura SJ
        • et al.
        Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
        Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64 (Epub 2005 Oct 5.): 382-391
        • Mabanta SR
        • Mendenhall WM
        • Stringer SP
        • Cassisi NJ
        Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes.
        Head Neck. 1999; 21: 591-594
        • Goodwin Jr, WJ
        Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?.
        Laryngoscope. 2000; 110: 1-18
        • Okada Y
        • Mataga I
        • Katagiri M
        • Ishii K
        An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma: relationship between grade of histopathological malignancy and lymph nodes metastasis.
        Int J Oral Maxillofac Surg. 2003; 32: 284-288
        • Leitner C
        • Rogers SN
        • Lowe D
        • Magennis P
        Death certification in patients whose primary treatment for oral and oropharyngeal carcinoma was operation: 1992-1997.
        Br J Oral Maxillofac Surg. 2001; 39: 204-209
      3. Kademani D, Lewis J, Koka S, Lamb D, Rallis D, Keller E. Analysis of cause of death and patient survival in T1 oral squamous cell carcinoma. J Oral Maxillofac Surg. In press.

        • Leon X
        • Quer M
        • Orus C
        • del Prado Venegas M
        • Lopez M
        Distant metastases in head and neck cancer patients who achieved loco-regional control.
        Head Neck. 2000; 22: 680-686
        • Caplan DJ
        • Hertz-Picciotto I
        Racial differences in survival of oral and pharyngeal cancer patients in North Carolina.
        J Public Health Dent. 1998; 58: 36-43
        • Goldberg HI
        • Lockwood SA
        • Wyatt SW
        • Crossett LS
        Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987.
        Cancer. 1994; 74: 565-572
        • Shah JP
        • Cendon RA
        • Farr HW
        • Strong EW
        Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck.
        Am J Surg. 1976; 132: 504-507

      Linked Article

      • CORRECTION
        Mayo Clinic ProceedingsVol. 82Issue 8
        • Preview
          Incorrect sentence and incorrect tumor stage: In the article by Kademani entitled “Oral Cancer,” published in the July 2007 issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2007;82:878-887), an incorrect sentence was published in the abstract and an incorrect tumor stage was published in the legend to Figure 6. The second sentence of the abstract should read as follows: Of the 615,000 new cases of head and neck tumors reported worldwide in 2000, 300,000 were primary oral cavity squamous cell carcinomas.
        • Full-Text
        • PDF